4//SEC Filing
Roberts M Scot 4
Accession 0001104659-24-010780
CIK 0001326190other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 6:02 PM ET
Size
15.4 KB
Accession
0001104659-24-010780
Insider Transaction Report
Form 4
Roberts M Scot
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock, par value $0.0001
2024-02-01+6,166→ 39,016 total - Exercise/Conversion
Restricted Stock Units
2024-02-02−7,775→ 15,550 total→ Common Stock, par value $0.0001 (7,775 underlying) - Exercise/Conversion
Common Stock, par value $0.0001
2024-02-02+7,775→ 44,990 total - Tax Payment
Common Stock, par value $0.0001
2024-02-01$9.88/sh−1,801$17,794→ 37,215 total - Tax Payment
Common Stock, par value $0.0001
2024-02-02$9.32/sh−2,330$21,716→ 42,660 total - Exercise/Conversion
Restricted Stock Units
2024-02-01−6,166→ 6,166 total→ Common Stock, par value $0.0001 (6,166 underlying)
Holdings
- 15(indirect: By Spouse)
Common Stock, par value $0.0001
Footnotes (4)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
- [F2]Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs.
- [F3]The RSUs become vested in substantially equal annual installments over the 4 years following February 1, 2021, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.
- [F4]The RSUs become vested in substantially equal annual installments over the 4 years following February 2, 2022, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.
Documents
Issuer
Altimmune, Inc.
CIK 0001326190
Entity typeother
Related Parties
1- filerCIK 0001705905
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 6:02 PM ET
- Size
- 15.4 KB